GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (OTCPK:LBPWQ) » Definitions » 3-Year Revenue Growth Rate

4d pharma (4d pharma) 3-Year Revenue Growth Rate : 0.00% (As of Dec. 2021)


View and export this data going back to 2021. Start your Free Trial

What is 4d pharma 3-Year Revenue Growth Rate?

4d pharma's Revenue per Share for the six months ended in Dec. 2021 was $0.00.

During the past 12 months, 4d pharma's average Revenue per Share Growth Rate was -40.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Competitive Comparison of 4d pharma's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, 4d pharma's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4d pharma's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4d pharma's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where 4d pharma's 3-Year Revenue Growth Rate falls into.



4d pharma 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


4d pharma  (OTCPK:LBPWQ) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


4d pharma 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of 4d pharma's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


4d pharma (4d pharma) Business Description

Traded in Other Exchanges
N/A
Address
9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.

4d pharma (4d pharma) Headlines

From GuruFocus

4D pharma to Participate in Jefferies London Healthcare Conference

By Business Wire Business Wire 11-11-2021

4D pharma Announces Passing of Chief Financial Officer John Beck

By Business Wire Business Wire 07-26-2021

4D pharma to Present at the H.C. Wainwright BioConnect Conference

By Business Wire Business Wire 01-05-2022

4D pharma to Present at the Microbiome Movement Drug Development Summit

By Business Wire Business Wire 06-22-2021